- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Outsmarting trogocytosis to boost CAR NK/T cell therapy ; volume:22 ; number:1 ; day:16 ; month:11 ; year:2023 ; pages:1-14 ; date:12.2023
Molecular cancer ; 22, Heft 1 (16.11.2023), 1-14, 12.2023
- Creator
-
Ramezani, Faezeh
Panahi Meymandi, Ahmad Reza
Akbari, Behnia
Tamtaji, Omid Reza
Mirzaei, Hamed
Brown, Christine E.
Mirzaei, Hamid Reza
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-023-01894-9
- URN
-
urn:nbn:de:101:1-2024013121022213973205
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ramezani, Faezeh
- Panahi Meymandi, Ahmad Reza
- Akbari, Behnia
- Tamtaji, Omid Reza
- Mirzaei, Hamed
- Brown, Christine E.
- Mirzaei, Hamid Reza
- SpringerLink (Online service)
Other Objects (12)
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Extranodal NK/T cell lymphoma mimicking Behçet's syndrome
CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma
Impaired NK and NKT cells immunobiology in rheumatoid arthritis
Molecular pathogenic pathways in extranodal NK/T cell lymphoma
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
NK and NKT-Like Cells in Patients with Recurrent Furunculosis
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
Biomarkers as targets for CAR-T/NK cell therapy in AML
NK cell differentiation, functionality and education are imprinted by activated NKT cells
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Extranodal NK/T cell lymphoma mimicking Behçet's syndrome
CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma
Impaired NK and NKT cells immunobiology in rheumatoid arthritis
Molecular pathogenic pathways in extranodal NK/T cell lymphoma
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
NK and NKT-Like Cells in Patients with Recurrent Furunculosis
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
Biomarkers as targets for CAR-T/NK cell therapy in AML
NK cell differentiation, functionality and education are imprinted by activated NKT cells
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Extranodal NK/T cell lymphoma mimicking Behçet's syndrome
CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma
Impaired NK and NKT cells immunobiology in rheumatoid arthritis
Molecular pathogenic pathways in extranodal NK/T cell lymphoma
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
NK and NKT-Like Cells in Patients with Recurrent Furunculosis
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
Biomarkers as targets for CAR-T/NK cell therapy in AML